The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bizily Scott since 2023.
This trader's CIK number is 1920738.
At the time of last reporting, Bizily Scott was the Chief Legal Officer of 4d Molecular Therapeutics, Inc.. (stock ticker symbol FDMT).
Also see all insider trading activities at 4d Molecular Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | FDMT | 0 | $0 | 31,730 | $871,547 | 31,730 | $398,387 |
| 2023 | FDMT | 0 | $0 | 11,995 | $237,715 | 11,250 | $84,634 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-16 | FDMT | Option Ex | 500 | 6.49 | 3,245 |
| 2024-09-16 | FDMT | Sale | 500 | 16.33 | 8,164 |
| 2024-08-19 | FDMT | Option Ex | 500 | 6.49 | 3,245 |
| 2024-08-19 | FDMT | Sale | 500 | 15.00 | 7,500 |
| 2024-07-16 | FDMT | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-07-16 | FDMT | Sale | 1,750 | 27.11 | 47,442 |
| 2024-07-11 | FDMT | Option Ex | 1,996 | 15.78 | 31,496 |
| 2024-07-11 | FDMT | Sale | 1,996 | 25.00 | 49,900 |
| 2024-07-01 | FDMT | Sale | 4,248 | 21.36 | 90,758 |
| 2024-07-01 | FDMT | Option Ex | 4,248 | 7.26 | 30,861 |
| 2024-06-17 | FDMT | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-06-17 | FDMT | Sale | 1,750 | 23.71 | 41,494 |
| 2024-05-16 | FDMT | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-05-16 | FDMT | Sale | 1,750 | 25.55 | 44,709 |
| 2024-04-16 | FDMT | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-04-16 | FDMT | Sale | 1,750 | 25.74 | 45,045 |
| 2024-03-27 | FDMT | Option Ex | 5,833 | 25.98 | 151,541 |
| 2024-03-27 | FDMT | Sale | 5,833 | 35.04 | 204,411 |
| 2024-03-18 | FDMT | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-03-18 | FDMT | Sale | 1,750 | 31.27 | 54,722 |
| 2024-02-27 | FDMT | Option Ex | 1,909 | 20.24 | 38,638 |
| 2024-02-27 | FDMT | Sale | 1,909 | 30.00 | 57,270 |
| 2024-02-16 | FDMT | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-02-16 | FDMT | Sale | 1,750 | 27.67 | 48,422 |
| 2024-02-08 | FDMT | Sale | 6,244 | 27.50 | 171,710 |
| 2024-02-08 | FDMT | Option Ex | 6,244 | 10.10 | 63,083 |
| 2023-06-08 | FMDT | Option Ex | 3,750 | 8.04 | 30,149 |
| 2023-06-08 | FMDT | Sale | 3,750 | 20.85 | 78,187 |
| 2023-06-01 | FMDT | Option Ex | 1,875 | 6.49 | 12,168 |
| 2023-06-01 | FMDT | Sale | 2,247 | 18.31 | 41,142 |
| 2023-04-21 | FDMT | Option Ex | 3,750 | 8.04 | 30,149 |
| 2023-04-21 | FDMT | Sale | 3,750 | 20.00 | 75,000 |
| 2023-03-01 | FDMT | Option Ex | 1,875 | 6.49 | 12,168 |
| 2023-03-01 | FDMT | Sale | 2,248 | 19.30 | 43,386 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bizily Scott (Chief Legal Officer of 4d Molecular Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.